4.5 Article

A concordance index for matched case-control studies with applications in cancer risk

Journal

STATISTICS IN MEDICINE
Volume 34, Issue 3, Pages 396-405

Publisher

WILEY-BLACKWELL
DOI: 10.1002/sim.6335

Keywords

case-control studies; classification; discrimination; matching

Funding

  1. Cancer Research U.K. [C569/A10404]
  2. Cancer Research UK [16891] Funding Source: researchfish

Ask authors/readers for more resources

In unmatched case-control studies, the area under the receiver operating characteristic (ROC) curve (AUC) may be used to measure how well a variable discriminates between cases and controls. The AUC is sometimes used in matched case-control studies by ignoring matching, but it lacks interpretation because it is not based on an estimate of the ROC for the population of interest. We introduce an alternative measure of discrimination that is the concordance of risk factors conditional on the matching factors. Parametric and non-parametric estimators are given for different matching scenarios, and applied to real data from breast and lung cancer case-control studies. Diagnostic plots to verify the constancy of discrimination over matching factors are demonstrated. The proposed simple measure is easy to use, interpret, more efficient than unmatched AUC statistics and may be applied to compare the conditional discrimination performance of risk factors. Copyright (c) 2014 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Hilary A. Robbins, Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed, Matthew T. Warkentin, Karl Smith-Byrne, Yonathan Brhane, David Muller, Xiaoshuang Feng, Demetrius Albanes, Melinda C. Aldrich, Alan A. Arslan, Julie Bassett, Christine D. Berg, Qiuyin Cai, Chu Chen, Michael P. A. Davies, Brenda Diergaarde, John K. Field, Neal D. Freedman, Wen-Yi Huang, Mikael Johansson, Michael Jones, Woon-Puay Koh, Stephen Lam, Qing Lan, Arnulf Langhammer, Linda M. Liao, Geoffrey Liu, Reza Malekzadeh, Roger L. Milne, Luis M. Montuenga, Thomas Rohan, Howard D. Sesso, Gianluca Severi, Mahdi Sheikh, Rashmi Sinha, Xiao-Ou Shu, Victoria L. Stevens, Martin C. Tammemaegi, Lesley F. Tinker, Kala Visvanathan, Ying Wang, Renwei Wang, Stephanie J. Weinstein, Emily White, David Wilson, Jian-Min Yuan, Xuehong Zhang, Wei Zheng, Christopher I. Amos, Paul Brennan, Mattias Johansson, Rayjean J. Hung

Summary: The INTEGRAL program aims to develop tools for optimizing LDCT lung cancer screening. It includes the Risk Biomarker and Nodule Malignancy projects, which investigate circulating protein markers for identifying individuals likely to benefit from screening and distinguishing benign versus malignant nodules. A total of 1161 and 1078 proteins were measured, and 21 proteins were selected for performance evaluation in the Risk Biomarker and Nodule Malignancy projects.

ANNALS OF EPIDEMIOLOGY (2023)

Article Oncology

Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY)

Thomas Behrens, Calvin Ge, Roel Vermeulen, Benjamin Kendzia, Ann Olsson, Joachim Schuez, Hans Kromhout, Beate Pesch, Susan Peters, Luetzen Portengen, Per Gustavsson, Dario Mirabelli, Pascal Guenel, Daniele Luce, Dario Consonni, Neil E. Caporaso, Maria Teresa Landi, John K. Field, Stefan Karrasch, Heinz-Erich Wichmann, Jack Siemiatycki, Marie-Elise Parent, Lorenzo Richiardi, Lorenzo Simonato, Karl-Heinz Joeckel, Wolfgang Ahrens, Hermann Pohlabeln, Guillermo Fernandez-Tardon, David Zaridze, John R. McLaughlin, Paul A. Demers, Beata Swiatkowska, Jolanta Lissowska, Tamas Pandics, Eleonora Fabianova, Dana Mates, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Paolo Boffetta, Bas Bueno-de-Mesquita, Francesco Forastiere, Kurt Straif, Thomas Bruening

Summary: Limited evidence exists regarding the exposure-effect relationship between lung-cancer risk and hexavalent chromium (Cr(VI)) or nickel. This study found that occupational exposure to Cr(VI) and nickel was associated with lung-cancer risks, particularly in men. In men, the highest quartile of cumulative exposure to CR(VI) and nickel were both significantly associated with increased odds ratios for lung cancer.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Public, Environmental & Occupational Health

Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester

Mary Pegington, Michelle Harvie, Elaine F. Harkness, Adam Brentnall, Lee Malcomson, Jake Southworth, Jill Fox, Anthony Howell, Jack Cuzick, D. Gareth Evans

Summary: Obesity in early adulthood is associated with lower breast cancer rates later in life, but the broader implications of higher weight are less known. This study examined the association between obesity in early adulthood and body mass index (BMI) change with all-cause mortality. The results showed that women who were overweight or obese at 20 years old had a higher mortality rate compared to those with a healthy weight.

BMC WOMENS HEALTH (2023)

Article Obstetrics & Gynecology

Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis

Xia Wei, Samuel Oxley, Michail Sideris, Ashwin Kalra, Adam Brentnall, Li Sun, Li Yang, Rosa Legood, Ranjit Manchanda

Summary: The study aimed to assess the impact of risk-reducing surgery on quality of life for breast cancer and ovarian cancer prevention. The results showed that risk-reducing mastectomy and risk-reducing salpingo-oophorectomy can reduce cancer-related distress and do not affect health-related quality of life. However, body image problems should be considered after risk-reducing mastectomy, and sexual dysfunction and menopause symptoms after risk-reducing salpingo-oophorectomy. Risk-reducing early salpingectomy and delayed oophorectomy may be a promising alternative to mitigate quality of life-related risks.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Article Oncology

Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)

D. Gareth Evans, Lorna McWilliams, Susan Astley, Adam R. Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W. Duffy, Louise S. Gorman, Elaine F. Harkness, Fiona Harrison, Michelle Harvie, Andrew Jerrison, Matthew Machin, Anthony J. Maxwell, Sacha J. Howell, Stuart J. Wright, Katherine Payne, Nadeem Qureshi, Helen Ruane, Jake Southworth, Lynne Fox, Sarah Bowers, Gillian Hutchinson, Emma Thorpe, Fiona Ulph, Victoria Woof, Anthony Howell, David P. French

Summary: The study developed BC-Predict, a risk assessment tool that collects standard risk factor information, mammographic density, and Polygenic Risk Score (PRS) to predict the risk of breast cancer. The results showed that inviting women at high and moderate risk for additional screening and preventive measures can increase the uptake of preventive medication.

BRITISH JOURNAL OF CANCER (2023)

Article Medicine, Research & Experimental

Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri

Adam R. Brentnall, Chris Mathews, Sandy Beare, Jennifer Ching, Michelle Sleeth, Peter Sasieni

Summary: A computer algorithm was developed to target trial invitations and address healthy volunteer effects and inequity in health research studies. The algorithm sends invitations by sampling from lists generated by the algorithm, with a tilt towards less likely groups to achieve equity, and requires a minimum expected event rate for the primary outcome.

CLINICAL TRIALS (2023)

Article Health Care Sciences & Services

Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman

Jeremy S. S. Paige, Christoph I. I. Lee, Pin-Chieh Wang, William Hsu, Adam R. R. Brentnall, Anne C. C. Hoyt, Arash Naeim, Joann G. G. Elmore

Summary: This study compared the accuracy and agreement of three breast cancer risk prediction models and found substantial variability in individual risk categorization. Depending on the model and risk threshold used, there were significant differences in breast cancer risk estimates for individuals. This variability can have adverse effects on screening, prevention, and quality of life, and clinicians need to be aware of the differences between models and the false-positive and false-negative rates when discussing with patients.

JOURNAL OF GENERAL INTERNAL MEDICINE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of an AI Model to Assess Future Breast Cancer Risk

Celeste Damiani, Grigorios Kalliatakis, Muthyala Sreenivas, Miaad Al-Attar, Janice Rose, Clare Pudney, Emily F. Lane, Jack Cuzick, Giovanni Montana, Adam R. Brentnall

Summary: This study evaluated the accuracy of a deep learning algorithm based on digital mammograms for breast cancer risk assessment. A retrospective observational matched case-control study was conducted using data from the National Health Service Breast Screening Programme in the United Kingdom. The AI model had an average AUC of 0.68 and a calibration slope of 1.13, showing similar accuracy in assessing the risk of early and advanced breast cancer.

RADIOLOGY (2023)

Article Oncology

Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK

Samuel Oxley, Ashwin Kalra, Michail Sideris, Nicole Itzkowitz, Olivia Evans, Emma Christine Atakpa, Adam R. Brentnall, Nina Dworschak, Faiza Gaba, Rhian Gabe, Sudha Sundar, Nick Wood, Shibani Nicum, Alexandra Taylor, Stephen Dobbs, W. Glenn McCluggage, Andy Nordin, Rosa Legood, Sean Kehoe, Sadaf Ghaem-Maghami, Ranjit Manchanda

Summary: This study examines the impact of multiple COVID-19 waves on gynaecological cancer services in the UK. Surveys were conducted after each wave, revealing a significant reduction in referrals, staffing shortages, and postponed surgeries during the first wave. Subsequent waves saw improvements in the number of referrals and staffing, but persistent staff shortages remained in 2022. The study highlights the need for adaptations in healthcare practices due to COVID-19.

CANCERS (2023)

Article Genetics & Heredity

Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent

Eleanor Roberts, Elke M. van Veen, Helen Byers, Ofra Barnett-Griness, Naomi Gronich, Flavio Lejbkowicz, Mila Pinchev, Miriam J. Smith, Anthony Howell, William G. Newman, Emma R. Woodward, Elaine F. Harkness, Adam R. Brentnall, Jack Cuzick, Gad Rennert, Sacha J. Howell, D. . Gareth Evans

Summary: Polygenic risk scores (PRSs) are an important part of accurate breast cancer risk prediction, but they need to be calibrated for different ethnicities. This study found that commercially available PRSs, which assume that Ashkenazi Jewish (AJ) population is of White European (WE) origin, do not accurately predict breast cancer risk in AJ women due to differences in effect allele frequencies. It is necessary to recalibrate PRSs using AJ-specific effect allele frequencies.

GENETICS IN MEDICINE (2023)

Editorial Material Respiratory System

Road map to improve the quality of lung cancer risk data

John K. Field

THORAX (2023)

Article Medicine, General & Internal

Plasma protein biomarkers for early prediction of lung cancer

Michael P. A. Davies, Takahiro Sato, Haitham Ashoor, Liping Hou, Triantafillos Liloglou, Robert Yang, John K. Field

Summary: The study investigated the potential of plasma proteomes for lung cancer prediction and identified differentially expressed proteins and pathways associated with the presence and prediction of lung cancer.

EBIOMEDICINE (2023)

Review Oncology

Defining the road map to a UK national lung cancer screening programme

Emma L. O'Dowd, Richard W. Lee, Ahsan R. Akram, Emily C. Bartlett, Stephen H. Bradley, Kate Brain, Matthew E. J. Callister, Yan Chen, Anand Devaraj, Sinan R. Eccles, John K. Field, Jesme Fox, Seamus Grundy, Sam M. Janes, Martin Ledson, Melanie MacKean, Anne Mackie, Kieran G. McManus, Rachael L. Murray, Arjun Nair, Samantha L. Quaife, Robert Rintoul, Anne Stevenson, Yvonne Summers, Louise S. Wilkinson, Richard Booton, David R. Baldwint, Philip Crosbie

Summary: Lung cancer screening with low-dose CT has been recommended by the UK National Screening Committee based on trials showing a reduction in lung cancer mortality. The UK has made significant progress in addressing logistical issues and implementing targeted lung cancer screening through clinical trials and the NHS England Targeted Lung Health Check Programme. This Policy Review provides a summary of the consensus and key requirements for effective implementation of a screening programme, and can serve as a valuable resource for countries planning their own lung cancer screenings.

LANCET ONCOLOGY (2023)

Article Oncology

Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study

Emma C. Atakpa, Diana S. M. Buist, Erin J. Aiello Bowles, Jack Cuzick, Adam R. Brentnall

Summary: Longitudinal breast density measurement may be more reliable than the most recent observation method for breast cancer risk estimation. It has the potential to improve individual breast cancer risk estimation in women attending mammography screening.

BREAST CANCER RESEARCH (2023)

Article Health Care Sciences & Services

An optimization framework to guide the choice of thresholds for risk-based cancer screening

Adam R. Brentnall, Emma C. Atakpa, Harry Hill, Ruggiero Santeramo, Celeste Damiani, Jack Cuzick, Giovanni Montana, Stephen W. Duffy

Summary: This study develops a framework to select risk groups by considering both model performance and available interventions. It applies the framework to guide breast cancer screening intervals and expects to reduce the number of advanced cancers by optimizing the selection strategy for risk groups.

NPJ DIGITAL MEDICINE (2023)

No Data Available